Six-year follow up of silodosin monotherapy for the treatment of lower urinary tract symptoms suggestive of benign prostatic hyperplasia: What are the factors for continuation or withdrawal?
about
Genetic association between PSA-158G/A polymorphism and the susceptibility of benign prostatic hyperplasia: a meta-analysis.New medical treatments for lower urinary tract symptoms due to benign prostatic hyperplasia and future perspectivesThe Persistence of Silodosin Monotherapy and the Reasons for Withdrawal from Treatment of Previously Untreated Japanese Patients with Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia.Novel LC-MS/MS method for the quantification of silodosin and its metabolites in human plasma.
P2860
Six-year follow up of silodosin monotherapy for the treatment of lower urinary tract symptoms suggestive of benign prostatic hyperplasia: What are the factors for continuation or withdrawal?
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
Six-year follow up of silodosi ...... or continuation or withdrawal?
@en
Six-year follow up of silodosi ...... or continuation or withdrawal?
@nl
type
label
Six-year follow up of silodosi ...... or continuation or withdrawal?
@en
Six-year follow up of silodosi ...... or continuation or withdrawal?
@nl
prefLabel
Six-year follow up of silodosi ...... or continuation or withdrawal?
@en
Six-year follow up of silodosi ...... or continuation or withdrawal?
@nl
P2093
P2860
P356
P1476
Six-year follow up of silodosi ...... or continuation or withdrawal?
@en
P2093
Chiharu Shibata
Takao Kamai
Tomonori Yamanishi
Tomoyuki Uchiyama
P2860
P304
P356
10.1111/IJU.12915
P50
P577
2015-08-27T00:00:00Z